Vermont

Effective 10/14/21, pharmacies may submit claims for administration of a booster dose of the Pfizer-BioNTech COVID-19 vaccine for dates of service on or after September 10, 2021. The Department of Vermont Health Access issued an updated guidance reminds pharmacies for any additional questions please contact the Healthcare Pharmacy Help Desk at 1-844-679-5362.

Also in Vermont, Governor Scott (R) signed a proclamation recognizing October as Pharmacists’ Month.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2021-10-22T09:24:57-04:00October 22, 2021|Vermont|

Arkansas

Gov. Asa Hutchinson (R) continues to work with legislative leaders to forge a consensus on income tax reductions before convening a special session this month. Pharmacies are advocating that the Governor include in his list of clean up items a repeal of the insulin rebate law (Act 1104) passed earlier this year.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-10-15T12:31:58-04:00October 15, 2021|Arkansas|

California

Gov. Gavin Newsom (D) signed the following bills:

  • AB 1064 (Chapter 655), authorizing a pharmacist to independently initiate and administer any vaccine that has been approved or authorized by the FDA and received an ACIP individual vaccine recommendation published by the CDC for persons 3 years of age and older and
  • AB 1533 (Chapter 629), extending the operation of the Board of Pharmacy until January 1, 2026. It also requires the Board to convene a workgroup to discuss whether moving to a standard of care enforcement model would be feasible and make recommendations to the Legislature about the outcome of these discussions through a report submitted to the Legislature; authorizes a pharmacist to initiate, adjust, or discontinue drug therapy for a patient under a collaborative practice agreement with any health care provider with prescriptive authority and authorizes a pharmacist to provide MAT pursuant to a state protocol; and authorizes an advanced practice pharmacist to initiate, adjust, or discontinue drug therapy without specifying the manner of such actions. Finally, it allows the Board to fine chain community pharmacy companies up to $100,000 for three or more repeated violations within five years, or a maximum of $150,000 for violations demonstrated to be the result of a written policy or which was expressly encouraged by the common owner or manager. In California, a chain community pharmacy is defined as a chain of 75 or more stores under the same ownership.

Also in California, the Board of Pharmacy has posted the following agendas and meeting materials for committee meetings on October 20:

Also in California, NACDS and the California Retailers Association worked with Magellan and the Department of Health Care Services (DHCS) to conduct an informational webinar on October 13 for chain pharmacies to learn about the important elements related to implementation of Medi-Cal Rx (start date of January 1, 2022). The presentation is currently available and an audio recording will be available soon. If your company would like to schedule its own training, please contact NACDS’ Sandra Guckian at 703-774-4801 or sguckian@nacds.org, and we will connect you directly to Magellan and DHCS to schedule the training.

Also in California, the Department of Health Care Services (DHCS) is working toward full Assumption of Operations (AOO) of all pharmacy services on January 1, 2022, to Medi-Cal Rx.  DHCS will transfer previously established Electronic Fund Transfer (EFT) account information from the existing Medi-Cal fee-for-service Fiscal Intermediary to Medi-Cal Rx.  If a pharmacy does not wish to have their EFT account information transferred to Medi-Cal Rx, there is an “opt out” option available until close of business on November 8, 2021. Pharmacy Providers may also provide new or modified EFT account information.  Details are available in the “Medi-Cal Rx Pharmacy Providers Electronic Fund Transfer Set Up and Opt Out provider bulletin.

Finally in California, the Board of Pharmacy amended and reissued several waivers related to staffing ratio and supervision associated with immunization-related activities. These will expire March 31, 2022, or until 30 days after the emergency declaration is lifted, whichever is sooner.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-10-20T15:58:50-04:00October 15, 2021|California|

Florida

The Agency for Health Care Administration (Agency) announced a CME learning opportunity free of cost for eligible providers. The Agency aims to reduce the impact of substance use disorders in Florida by increasing the capacity of health care providers to screen, briefly intervene, and refer to treatment (SBIRT) individuals with substance use disorder. In this online CME program, providers will learn how to use SBIRT in their daily practices. This learning event particularly emphasizes SBIRT practice tips in the evaluation and management of pregnant women. The CME is available to providers online from the University of Florida at the following link.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-10-15T12:32:55-04:00October 15, 2021|Florida|

Iowa

The Board of Pharmacy announced it is seeking pre-Notice comments on its draft statewide protocol for pharmacists to test and treat patients for COVID-19.  Comments may be submitted through October 22 to Sue Mears at sue.mears@iowa.gov.

Also in Iowa, the Board of Pharmacy alerted licensees and registrants about recent activities by individuals posing as employees of the Board, DEA and FDA.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-10-15T11:44:09-04:00October 15, 2021|Iowa|

Louisiana

Effective October 1st, the Department of Health’s (LDH) Medicaid Fee for Service (FFS) Pharmacy Program and Managed Care Organizations (MCOs), in consultation with the Drug Utilization Review (DUR) Board, began implementing quantity limits for select medications at the Point of Sale (POS):  Asthma/COPD Bronchodilator, Anticholinergic (COPD) – Inhalation Agents; Proton Pump Inhibitors (PPIs); Pulmonary Arterial Hypertension (PAH) Agents; Tasimelteon (Hetlioz LQ™) [a Sedative Hypnotic];Vericiguat (Verquvo®) in Heart Disease, Hyperlipidemia – Vasodilators, Coronary. LA FFS-MCO Qty Limits

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-10-15T11:43:09-04:00October 15, 2021|Louisiana|

Maryland

The following laws that passed in the 2021 Legislative session went into effect on October 1:

  • HB 429 This law allows therapeutic substitution under certain circumstances. It requires a pharmacist, or the pharmacist’s designee, to inform a consumer of the availability of a therapeutically equivalent brand name drug that is the lowest cost alternative to the originally prescribed drug or device and the cost difference between the equivalent drug or device and the prescribed drug for cash paying customers only. It does not apply to prescriptions reimbursed by a third-party payor. Also requires the pharmacy to provide written notice, or to maintain a record that indicates a patient was notified in writing or orally, that the generic product is equivalent to the brand name product.
  • SB 298 This law requires an owner of a pharmacy to provide notice of the closing of the pharmacy at least 14 days prior to the anticipated closing of the pharmacy, It also requires the notice to indicate the name of the pharmacy where customer prescriptions and records will transferred, and that a customer may request that their prescriptions and records be sent to another pharmacy. The Board of Pharmacy will have to promulgate regulation on this law.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2021-10-15T11:42:00-04:00October 15, 2021|Maryland|

Michigan

At the June quarterly Michigan Medicaid pharmacy provider liaison meeting, companies asked that Medicaid provide each of their corporate staff a list of claims for their respective stores tied to Medicaid errors that may have caused processing errors regarding cost share responsibility. They wanted their corporate staff to reprocess the claims for the stores and determine if there are any issues with the claims.  Michigan Medicaid staff is looking for the most appropriate contact for each company. Medicaid is looking for each company to email a list of their pharmacy NPIs to MDHHSPharmacyServices@michigan.gov.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2021-10-15T12:35:15-04:00October 15, 2021|Michigan|

Missouri

The Department of Social Services MO HealthNet Division is implementing new edits effective October 21st requiring Medicaid participants to receive a 90-day supply select medications.

Also in Missouri, prescribers of controlled substances for MO HealthNet (Medicaid) participants are required to check the Prescription Drug Monitoring Program (PDMP) prior to prescribing a controlled substance starting on October 1, 2021. The FAQ is available under Frequently Updated Documents and is titled Prescription Drug Monitoring Program (PDMP) FAQ.

Finally in Missouri, the Board of Pharmacy is holding a virtual meeting on October 19 and 20 MO BOP Virtual Meeting.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-10-15T11:39:58-04:00October 15, 2021|Missouri|
Go to Top